AC Immune
ACIU
#8651
Rank
โ‚ฌ0.20 B
Marketcap
2,02ย โ‚ฌ
Share price
2.22%
Change (1 day)
13.82%
Change (1 year)

Revenue for AC Immune (ACIU)

Revenue in 2026 (TTM): โ‚ฌ3.97 Million

According to AC Immune's latest financial reports the company's current revenue (TTM ) is โ‚ฌ4.08 Million. In 2025 the company made a revenue of โ‚ฌ3.72 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ30.91 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AC Immune from 2015 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ3.97 M6.84%
2025 โ‚ฌ3.72 M-87.96%
2024 โ‚ฌ30.91 M94.13%
2023 โ‚ฌ15.92 M327.87%
2022 โ‚ฌ3.72 M
2021 N/A-100%
2020 โ‚ฌ13.17 M-86.74%
2019 โ‚ฌ99.39 M1446.85%
2018 โ‚ฌ6.42 M-62.86%
2017 โ‚ฌ17.3 M-23.31%
2016 โ‚ฌ22.56 M-39.44%
2015 โ‚ฌ37.25 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA